IRCT20210807052098N1Not yet recruitingPhase 4
Investigation of intravenous dexmedetomidine administration effect on patency of arteriovenous fistula in patients undergoing arteriovenous fistula creation surgery
Ghoum University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 80 years (—)
- Sex
- All
Inclusion Criteria
- •patients with renal failure and dependent on dialysis
- •candidate for arteriovenous fistula surgery
- •without heart failure
- •age below eighty years
Exclusion Criteria
- •The patient's unwillingness to participate in the study at any time during the study
- •Contraindications for the use of dexmedetomidine: severe heart block, severe bradycardia, severe heart failure, QT changes, hypotension, liver failure, intravascular volume depletion, allergy to alpha 2 agonists
- •age over 80 years
- •heart failure
Investigators
Similar Trials
Completed
Not Applicable
Benefits of dexmedetomidine with spinal anesthesia in patients undergoing lower limb surgeriesCTRI/2018/04/013359BLK Superspeciality Hospital150
Not yet recruiting
Not Applicable
comparing the effectiveness of two drugs (dexmeditomidine and clonidine) in laparoscopic cancer surgeries.CTRI/2019/06/019683PRASHANT HATTI
Recruiting
Not Applicable
Sedation during Awake Fiberoptic IntubatioRespiratorySurgerylaryngeal massPACTR201701001959580Mohamed Elsayed Afandy80
Not yet recruiting
Unknown
Efficacy of dexmedetomidine drug in addition to muscle block for pain relief in spine surgeryCTRI/2023/04/051398Department of Anaesthesia and Intensive Care
Completed
Not Applicable
Comparative study to evaluate the efficacy of dexmedetomidine via two routes i. e. intravenous and intrathecal in below knee surgeries under subarachnoid blockCTRI/2017/08/009546Dr Rajendra Prasad Government Medical College90
